<!DOCTYPE html>
<html>
<head>
<meta name="generator" content=
"HTML Tidy for HTML5 for Apple macOS version 5.6.0">
<meta http-equiv="Content-Type" content=
"text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:"Calibri Light";
        panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin-top:0in;
        margin-right:0in;
        margin-bottom:8.0pt;
        margin-left:0in;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
h1
        {mso-style-link:"Heading 1 Char";
        margin-top:12.0pt;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:0in;
        margin-bottom:.0001pt;
        line-height:107%;
        page-break-after:avoid;
        font-size:16.0pt;
        font-family:"Calibri Light",sans-serif;
        color:#2F5496;
        font-weight:normal;}
h3
        {mso-style-link:"Heading 3 Char";
        margin-top:2.0pt;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:0in;
        margin-bottom:.0001pt;
        line-height:107%;
        page-break-after:avoid;
        font-size:12.0pt;
        font-family:"Calibri Light",sans-serif;
        color:#1F3763;
        font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {margin-top:0in;
        margin-right:0in;
        margin-bottom:8.0pt;
        margin-left:.5in;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
        {margin-top:0in;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:.5in;
        margin-bottom:.0001pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
        {margin-top:0in;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:.5in;
        margin-bottom:.0001pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
        {margin-top:0in;
        margin-right:0in;
        margin-bottom:8.0pt;
        margin-left:.5in;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
span.Heading1Char
        {mso-style-name:"Heading 1 Char";
        mso-style-link:"Heading 1";
        font-family:"Calibri Light",sans-serif;
        color:#2F5496;}
span.Heading3Char
        {mso-style-name:"Heading 3 Char";
        mso-style-link:"Heading 3";
        font-family:"Calibri Light",sans-serif;
        color:#1F3763;}
.MsoChpDefault
        {font-family:"Calibri",sans-serif;}
.MsoPapDefault
        {margin-bottom:8.0pt;
        line-height:107%;}
@page WordSection1
        {size:595.3pt 841.9pt;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
 /* List Definitions */
 ol
        {margin-bottom:0in;}
ul
        {margin-bottom:0in;}
-->
</style>
<title></title>
</head>
<body lang="EN-GB">
<div class="WordSection1">
<h1><span lang="EN-US" style=
'font-size:15.0pt;line-height:107%'>2016A08 Outline the
pharmacology of agents used in the acute management of hypertension
in pregnancy.</span></h1>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>List:</span></h3>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Intro</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Pregnancy-specific antihypertensives</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Other drugs</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Anaesthesia</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Intro:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="186" valign="top" style=
'width:139.25pt;border:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Causes of hypertension in pregnancy</span></p>
</td>
<td width="415" valign="top" style=
'width:311.55pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Pregnancy-induced hypertension</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Pre-eclampsia</span></p>
</td>
</tr>
<tr>
<td width="186" valign="top" style=
'width:139.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Teratogenic drugs</span></p>
</td>
<td width="415" valign="top" style=
'width:311.55pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">ACE inhibitors</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Angiotensin receptor
antagonists</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Beta blockers</span></p>
</td>
</tr>
<tr>
<td width="186" valign="top" style=
'width:139.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Other contra-indicated drugs</span></p>
</td>
<td width="415" valign="top" style=
'width:311.55pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraph" style=
'margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt;line-height: normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">GTN -&gt; foetal
methaemoglobinaemia</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Pregnancy-specific
agents:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="80" valign="top" style=
'width:60.35pt;border:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">&nbsp;</span></p>
</td>
<td width="291" valign="top" style=
'width:218.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<b><span lang="EN-US">Pharmacodynamics</span></b></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Mechanism of action (MoA)</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Side effects (SE)</span></p>
</td>
<td width="229" valign="top" style=
'width:172.05pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<b><span lang="EN-US">Pharmacokinetics</span></b></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Absorption (A)</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Distribution (D)</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Metabolism (M)</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Excretion (E)</span></p>
</td>
</tr>
<tr>
<td width="80" valign="top" style=
'width:60.35pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Labetalol</span></p>
</td>
<td width="291" valign="top" style=
'width:218.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">MoA:</span> <span lang=
"EN-US">&alpha;</span><sub><span lang=
"EN-US">1</span></sub><span lang="EN-US">,</span> <span lang=
"EN-US">&beta;</span><sub><span lang=
"EN-US">1</span></sub><span lang="EN-US">,</span> <span lang=
"EN-US">&beta;</span><sub><span lang="EN-US">2</span></sub>
<span lang="EN-US">antagonist</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:28.25pt;margin-bottom:.0001pt;text-indent:-9.0pt; line-height:normal'>
<span lang="EN-US" style='font-family:"Courier New"'>o
</span><span lang="EN-US">IV</span> <span lang=
"EN-US">&alpha;</span><span lang="EN-US">:</span><span lang=
"EN-US">&beta;</span> <span lang="EN-US">1:7</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:28.25pt;margin-bottom:.0001pt;text-indent:-9.0pt; line-height:normal'>
<span lang="EN-US" style='font-family:"Courier New"'>o
</span><span lang="EN-US">PO</span> <span lang=
"EN-US">&alpha;</span><span lang="EN-US">:</span><span lang=
"EN-US">&beta;</span> <span lang="EN-US">1:3</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Isomers: SS/SR inactive, RS</span>
<span lang="EN-US">&alpha;</span><span lang="EN-US">, RR</span>
<span lang="EN-US">&alpha;</span> <span lang="EN-US">and</span>
<span lang="EN-US">&beta;</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Membrane-stabilising (VdNaC
blockade)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Weak ISA</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">SE: bradycardia, bronchospasm (avoid in
asthma)</span></p>
</td>
<td width="229" valign="top" style=
'width:172.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">IV 20-40mg q2 mins</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">PO 200-400mg bd</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Inset 2-5 min, duration 2-4h</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">A: oral bioav 25%</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">D: V<sub>D</sub> 10L/kg, 50% protein
bound</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">M: hepatic,
t<sub>1/2</sub></span><sub><span lang="EN-US">&beta;</span></sub>
<span lang="EN-US">6-8 hours</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">E: urine</span></p>
</td>
</tr>
<tr>
<td width="80" valign="top" style=
'width:60.35pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Hydralazine</span></p>
</td>
<td width="291" valign="top" style=
'width:218.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Direct acting vasodilator</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">MoA unknown</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">SEs: tachycardia, myocardial ischaemia,
headache, flushing, peripheral oedema, SLE-like syndrome,
peripheral neuropathy</span></p>
</td>
<td width="229" valign="top" style=
'width:172.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">IV 5-10mg q15 min</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Onset 5-20 min, duration 2-6 h</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">A: oral bioav10-30%</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">D: V<sub>D</sub> 0.5L/kg, 90% protein
bound</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">M: N-acetylation (subject to
polymorphism; t<sub>1/2</sub></span><sub><span lang=
"EN-US">&beta;</span></sub> <span lang="EN-US">3-7
hours)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">E: urine</span></p>
</td>
</tr>
<tr>
<td width="80" valign="top" style=
'width:60.35pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Magnesium</span></p>
</td>
<td width="291" valign="top" style=
'width:218.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">MoA: physiological antagonist at
L-Ca<sup>2+</sup> channel</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;line-height:normal'>
<span lang="EN-US">&DownArrow;Risk of seizures in pre-eclampsia<br>
&DownArrow;SVR</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">SE: sedation, resp depression</span></p>
</td>
<td width="229" valign="top" style=
'width:172.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">IV 10mmol slow push in severe
PET</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Onset &lt;1 min</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">D: ICF 30mM, ECF 1mM; bone ++</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">E: urine, faeces</span></p>
</td>
</tr>
<tr>
<td width="80" valign="top" style=
'width:60.35pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Nifedipine</span></p>
</td>
<td width="291" valign="top" style=
'width:218.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Dihydropyridine peripheral
L-Ca<sup>2+</sup> antagonist</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Vasodilatation -&gt;
&DownArrow;SVR</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">SE: reflex &ShortUpArrow;HR, dizziness,
oedema</span></p>
</td>
<td width="229" valign="top" style=
'width:172.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">PO 10-20mg q6h</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Onset: 30-45 mins</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">A: oral bioav 90%</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">D: V<sub>D</sub> 0.7L/kg, 90% protein
bound</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">M: hepatic CYP450</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">E: urine</span></p>
</td>
</tr>
<tr>
<td width="80" valign="top" style=
'width:60.35pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Methyldopa</span></p>
</td>
<td width="291" valign="top" style=
'width:218.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Prodrug: DBH to</span> <span lang=
"EN-US">&alpha;</span><span lang="EN-US">-methylnoradrenaline -&gt;
central</span> <span lang="EN-US">&alpha;</span><sub><span lang=
"EN-US">2</span></sub> <span lang="EN-US">agonist -&gt;
&DownArrow;SNS outflow</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Also inhibits DOPA decarboxylase -&gt;
&DownArrow;DA, NAd</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">SE: Parkinsonism, depression</span></p>
</td>
<td width="229" valign="top" style=
'width:172.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">200-400mg bd only</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Not suitable for crisis</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">A: oral bioav 25%</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">D: V<sub>D</sub> 0.6L/kg, &lt;15% protein
bound</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">M: activation in CNS</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Other drugs:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="78" valign="top" style=
'width:58.25pt;border:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Alfentanil</span></p>
</td>
<td width="246" valign="top" style=
'width:184.5pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">&DownArrow;Pressor response to
laryngoscopy</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">MoA: MOP agonist -&gt; &DownArrow;SNS
output</span></p>
</td>
<td width="277" valign="top" style=
'width:208.05pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">IV 10-20mcg/kg bolus</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Peak 1-1.5 min, offset 5 min</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Offset by distribution</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">M: CYP3A4</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">E: urine</span></p>
</td>
</tr>
<tr>
<td width="78" valign="top" style=
'width:58.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Esmolol</span></p>
</td>
<td width="246" valign="top" style=
'width:184.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">&DownArrow;Pressor response to
laryngoscopy</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">MoA:</span> <span lang=
"EN-US">&beta;</span><sub><span lang="EN-US">1</span></sub>
<span lang="EN-US">antagonist -&gt; &DownArrow;HR,
&DownArrow;contractility -&gt; &DownArrow;CO</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">SE: difficult to titrate
analgesics</span></p>
</td>
<td width="277" valign="top" style=
'width:208.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Bolus 0.5mg/kg over 30 seconds</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Infusion 0.05-2mg/kg/min</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">Onset 2-10 mins, offset
10-30mins</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">D: V<sub>D</sub> 3.5L/kg, 60% protein
bound</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">M: RBC esterase, Cl 285mL/kg/min, t1/2b
10 mins</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:5.75pt;margin-bottom:.0001pt;text-indent:-5.75pt; line-height:normal'>
<span lang="EN-US" style='font-family:Symbol'>&CenterDot;
</span><span lang="EN-US">E: urine</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Anaesthesia:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="72" valign="top" style=
'width:53.75pt;border:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Neuraxial</span></p>
</td>
<td width="529" valign="top" style=
'width:397.05pt;border:solid windowtext 1.0pt; border-left:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">e.g. epidural ropivacaine and fentanyl: blockade at spinal
nerve roots -&gt; &DownArrow;SNS output</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">Usually both anaesthetic (local) and analgesic
(opioid)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">Highly effective</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">T5-L2: &DownArrow;SVR, &DownArrow;mAP</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">If T1-4: &DownArrow;HR, &DownArrow;SVR,
&DownArrow;&DownArrow;mAP</span></p>
</td>
</tr>
<tr>
<td width="72" valign="top" style=
'width:53.75pt;border:solid windowtext 1.0pt; border-top:none;padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">General</span></p>
</td>
<td width="529" valign="top" style=
'width:397.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0in 5.4pt 0in 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">e.g. propofol (only under GA)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">MoA &DownArrow;mAP: L-Ca<sup>2+</sup> inhibition,
&ShortUpArrow;NO release, &DownArrow;SNS output from
medulla</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0in;margin-right:0in; margin-bottom:0in;margin-left:7.85pt;margin-bottom:.0001pt;text-indent:-7.85pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;</span></span> <span lang=
"EN-US">SEs: maternal and foetal anaesthesia, respiratory and
cardiovascular depression</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
<p class="MsoNormal" style=
'margin-bottom:0in;margin-bottom:.0001pt'><span lang=
"EN-US">&nbsp;</span></p>
</div>
</body>
</html>
